Institute of Genomics and Integrative Biology (IGIB), constituent lab of CSIR, has signed a MoU with TATA Sons for licensing of KNOWHOW for FELUDA in order to execute rapid diagnosis of COVID-19. The MoU aims to provide license which will enable transfer of the knowledge for scaling up the KNOWHOW in the form of a kit in order to employ it for COVID-19 testing on ground as soon as possible. Hence, as per MoU, CSIR-IGIB will now work along with TATA Sons to bring FELUDA for widespread use at the earliest.
Click Here To Get Test Series For SBI PO 2020
FNCAS9 Editor Linked Uniform Detection Assay (FELUDA) has been designed to alleviate the current COVID-19 situation and cater to mass testing. The main advantages of FELUDA is its affordability, relative ease of use as well as non-dependency on expensive Q-PCR machines.
Many cities around the world are given special names because of what they are best…
In ancient India, many powerful kings ruled large empires and were known for their bravery,…
Norway is a peaceful and beautiful country in Northern Europe. It is known for its…
The Unique Identification Authority of India (UIDAI) has taken a significant step towards improving public…
Odisha, a state in eastern India, has a rich history in culture, art and transport.…
Uttar Pradesh is one of the largest states in India and is known for its…